<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04145869</url>
  </required_header>
  <id_info>
    <org_study_id>IFC3</org_study_id>
    <nct_id>NCT04145869</nct_id>
  </id_info>
  <brief_title>Fluorescent Cholangiography During Acute Cholecystitis</brief_title>
  <official_title>Prospective Comparison of Intraoperative Fluorescent and X-ray Cholangiography for Visualisation of the Bile Duct Anatomy in Patients With Acute Cholecystitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hillerod Hospital, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the visualizationrate of fluorescent and X-ray cholangiography during
      laparoscopic cholecystectomy for acute cholecystitis
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visualizationrate</measure>
    <time_frame>1 hour</time_frame>
    <description>Percentage of patients with visualization of the structure: the cystic duct - common hepatic duct - common bile duct junction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visualizationrate</measure>
    <time_frame>1 hour</time_frame>
    <description>Percentage of patients with visualization of the structure2: right and left hepatic ducts, common hepatic duct, common bile duct, cystic duct</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bile duct stones</measure>
    <time_frame>1 hour</time_frame>
    <description>Percentage of patients with visualization of bile duct stones</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Cholecystitis</condition>
  <arm_group>
    <arm_group_label>Fluorescent cholangiography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative fluorescent cholangiography using an intravenous injection of 5mg Indocyanine green</description>
  </arm_group>
  <arm_group>
    <arm_group_label>X-ray cholangiography</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraoperative X-ray cholangiography using an intraductal (cystic duct) injection of Iohexol</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cholangiography</intervention_name>
    <description>All patients will be subjected to intraoperative fluorescent and concommitant X-ray cholangiography</description>
    <arm_group_label>Fluorescent cholangiography</arm_group_label>
    <arm_group_label>X-ray cholangiography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          -  Patient scheduled for acute laparoscopic cholecystectomy due to acute cholecystitis
             with ≤ 5 days of complaints (in Denmark the national consensus for surgical window)

        Exclusion criteria

          -  Laparoscopic operation converted to open operation prior to completed fluorescent and
             X-ray cholangiography

          -  Allergy towards iodine, Iohexol or indocyanine green

          -  Legally incompetent (any reason)

          -  Cholangitis (as defined above)15

          -  Withdrawal of inclusion consent at any time
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Northzealand Hospiral Hillerød</name>
      <address>
        <city>Hillerød</city>
        <state>Danmark</state>
        <zip>3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hvidovre University Hospital</name>
      <address>
        <city>Hvidovre</city>
        <state>Danmark</state>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zealand University Hospital Køge</name>
      <address>
        <city>Køge</city>
        <zip>4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 29, 2019</study_first_submitted>
  <study_first_submitted_qc>October 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2019</study_first_posted>
  <last_update_submitted>April 1, 2020</last_update_submitted>
  <last_update_submitted_qc>April 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Lars Lang Lehrskov</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Fluorescence</keyword>
  <keyword>Cholangriography</keyword>
  <keyword>Cholecystectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecystitis</mesh_term>
    <mesh_term>Acalculous Cholecystitis</mesh_term>
    <mesh_term>Cholecystitis, Acute</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

